SEARCH

SEARCH BY CITATION

References

  • BAMBER, B., REIFE, R.A., HAUGEN, H.S. & CLEGG, C.H. (1998). Oncostatin M stimulates excessive extracellular matrix accumulation in a transgenic mouse model of connective tissue disease. J. Mol. Med., 76, 6169.
  • BELVISI, M.G., SAUNDERS, M., YACOUB, M. & MITCHELL, J.A. (1998). Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growth. Br. J. Pharmacol., 125, 11021108.
  • BERNARD, C., MERVAL, R., LEBRET, M., DELERIVE, P., DUSANTER-FOURT, I., LEHOUX, S., CREMINON, C., STAELS, B., MACLOUF, J. & TEDGUI, A. (1999). Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells: synergy with interleukin-1 beta. Circ. Res., 85, 11241131.
  • BORDER, W.A. & NOBLE, N.A. (1994). Transforming growth factor beta in tissue fibrosis. New Engl. J. Med., 331, 12861292.
  • BORNFELDT, K.E., CAMPBELL, J.S., KOYAMA, H., ARGAST, G.M., LESLIE, C.C., RAINES, E.W., KREBS, E.G. & ROSS, R. (1997). The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. J. Clin. Invest., 100, 875885.
  • BREWSTER, C.E., HOWARTH, P.H., DJUKANOVIC, R., WILSON, J., HOLGATE, S.T. & ROCHE, W.R. (1990). Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol., 3, 507511.
  • BROWN, T.J., ROWE, J.M., LIU, J. & SHOYAB, M. (1991). Regulation of IL-6 expression by oncostatin M. J. Immunol., 147, 21752180.
  • CAMPA, J.S., MCANULTY, R.J. & LAURENT, G.J. (1990). Application of high-pressure liquid chromatography to studies of collagen production by isolated cells in culture. Anal. Biochem., 186, 2563.
  • CHAMBERS, R.C., DABBAGH, K., MCANULTY, R.J., GRAY, A.J., BLANC-BRUDE, O.P. & LAURENT, G.J. (1998). Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1. Biochem. J., 333, 121127.
  • CHUNG, K.F. & BARNES, P.J. (1999). Cytokines in asthma. Thorax, 54, 825857.
  • CICHY, J., ROSE-JOHN, S. & TRAVIS, J. (1998). Oncostatin M, leukemia inhibitory factor and interleukin 6 trigger different effects on α1-proteinase inhibitor synthesis in human lung derived epithelial cells. Biochem. J., 329, 335339.
  • DUNCAN, M.R., HASAN, A. & BERMAN, B. (1995). Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts. J. Invest. Dermatol., 104, 128133.
  • GIZYCKI, M.J., ADELROTH, E., ROGERS, A.V., O'BYRNE, P.M. & JEFFERY, P.K. (1997). Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am. J. Respir. Cell Mol. Biol., 16, 664673.
  • GRENIER, A., DEHOUX, M., BOUTTEN, A., ARCE-VICIOSO, M., DURAND, G., GOUGEROT-POCIDALO, M.A. & CHOLLET-MARTIN, S. (1999). Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood, 93, 14131421.
  • GROVE, R.I., EBERHARDT, C., ABID, S., MAZZUCCO, C., LIU, J., KIENER, P., TODARO, G. & SHOYAB, M. (1993). Oncostatin M is a mitogen for rabbit vascular smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A., 90, 823827.
  • GUTKIND, J.S. (1998). Cell growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene, 17, 13311342.
  • HEINRICH, P.C., BEHRMANN, I., MULLER-NEWEN, G., SCHAPER, F. & GRAEVE, L. (1998). Interleukin 6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J., 334, 297314.
  • IHN, H., LEROY, E.C. & TROJANOWSKA, M. (1997). Oncostatin M stimulates transcription of the human alpha2(I) collagen gene via the Sp1/Sp3-binding site. J. Biol. Chem., 272, 2466624672.
  • IHN, H. & TAMAKI, K. (2000). Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway. J. Immunol., 165, 21492155.
  • JEFFERY, P.K. (1991). Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 143, 11521158.
  • JILKA, R.L., WEINSTEIN, R.S., BELLIDO, T., PARFITT, A.M. & MANOLAGAS, S.C. (1998). Osteoblast programmed cell death (apoptosis)–modulation by growth factors and cytokines. J. Bone Min. Res., 13, 793802.
  • KEERTHISINGAM, C.B., JENKINS, R.G., HARRISON, N.K., HERNANDEZ-RODRIGUEZ, N.A., BOOTH, H., LAURENT, G.J., HART, S.L., FOSTER, M.L. & MCANULTY, R.J. (2001). Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol., 158, 14111422.
  • KNIGHT, D.A., ASOKANANTHAN, N., WATKINS, D.N., MISSO, N.L., THOMPSON, P.J. & STEWART, G.A. (2000). Oncostatin M synergises with house dust mite proteases to induce the production of PGE(2) from cultured lung epithelial cells. Br. J. Pharmacol., 131, 465472.
  • KNIGHT, D.A., CARROLL, N.G., LENZO, J.C., MCKAY, K.O., JAMES, A.L. & THOMPSON, P.J. (1999a). Immunohistochemical localisation of oncostatin M receptors in human airways: altered pattern of expression in asthma. Eur. Respir. J., 14, 528s.
  • KNIGHT, D.A., LYDELL, C.P., ZHOU, D., WEIR, T.D., SCHELLENBERG, R. & BAI, T.R. (1999b). Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release. Am. J. Respir. Cell Mol. Biol., 20, 834841.
  • LEVY, M.T., TROJANOWSKA, M. & REUBEN, A. (2000). Oncostatin M: a cytokine upregulated in human cirrhosis increases collagen production by human hepatic stellate cells. J. Hepatol., 32, 218226.
  • LI, W.Q. & ZAFARULLAH, M. (1998). Oncostatin m up-regulates tissue inhibitor of metalloproteinases-3 gene expression in artricular chondrocytes via de novo transcription, protein synthesis, and tyrosine kinase-and mitogen-activated protein kinase-dependent mechanisms. J. Immunol., 161, 50005007.
  • LIU, J.W., HADJOKAS, N., MOSLEY, B., ESTROV, Z., SPENCE, M.J. & VESTAL, R.E. (1998). Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells. Cytokine, 10, 295302.
  • MARTINEZ, E.J., OWA, T., SCHREIBER, S.L. & COREY, E.J. (1999). Pthalascidin, a synthetic anti-tmour agent with potency and mode of action comparable to ecteinascidin 743. Proc. Natl. Acad. Sci. U.S.A., 96, 34963501.
  • MCANULTY, R.J., HERNANDEZ-RODRIGUEZ, N.A., MUTSAERS, S.E., COKER, R.K. & LAURENT, G.J. (1997). Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem. J., 321, 639643.
  • MOSLEY, B., IMUS, C.D., FRIEND, D., BOIANI, N., THOMA, B., PARK, L.S. & COSMAN, D. (1996). Dual oncostatin M receptors. J. Biol. Chem., 50, 3263632643.
  • PAGES, G., LENORMAND, P., L'ALLEMAIN, G., CHAMBARD, J.C., MELOCHE, S. & POUYSSEGUR, J. (1993). Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. U.S.A., 90, 83198323.
  • POURTEAU, J., MIRSHAHI, F., LI, H., MURAINE, M., VINCENT, L., TEDGUI, A., VANNIER, J.-P., SORIA, J., VASSE, M. & SORIA, C. (1999). Cycloxygenase activity is necessary for the angiogenic properties of oncostatin M. FEBS Lett., 459, 15.
  • RICHARDS, C.D., KERR, C., TANAKA, M., HARA, J., MIYAJIMA, A., PENNICA, D., BOTELHO, F. & LANGDON, C.M. (1997). Regulation of tissue inhibitor of metalloproteinase-1 in fibroblast and acute phase proteins in hepatocytes in vitro by mouse oncostatin M, cardiotrophin-1, and IL-6. J. Immunol., 159, 24312436.
  • RICHARDS, C.D., SHOYAB, M., BROWN, T.J. & GAULDIE, J. (1993). Selective regulation of metalloproteinases inhibitor (TIMP-1) by Oncostatin M in fibroblasts in culture. J. Immunol., 150, 55965603.
  • ROSE, T.M. & BRUCE, A.G. (1991). Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc. Natl. Acad. Sci. U.S.A., 88, 86418645.
  • ROTH, M., NAUCK, M., TAMM, M., PERRUCHOUD, A., ZIESCHE, R. & BLOCK, L. (1995). Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of non-transformed cells. Proc. Natl. Acad. Sci., 92, 13121316.
  • TAGA, T. (1996). gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. J. Neurochem., 67, 110.
  • TAGA, T. (1997). gp130 and the interleukin-6 family of cytokines. Ann. Rev. Immunol., 15, 797819.
  • XIAO, L., PIMENTAL, D.R., AMIN, J.K., SINGH, K., SAWYER, D.B. & COLUCCI, W.S. (2001). MEK 1/2-ERK mediates α1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J. Mol. Cell. Cardiol., 33, 779787.
  • ZARLING, J.M., SHOYAB, M., MARQUARDT, H., HANSON, B., LIOUBIN, N. & TODARO, G.J. (1986). Oncostatin M: A growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl. Acad. Sci. U.S.A., 83, 97399743.
  • ZHENG, X., KNIGHT, D., ZHOU, D., WEIR, T., PEACOCK, C., SCHELLENBERG, R.R. & BAI, T. (1999). Leukemia inhibitory factor is synthesized and released by human eosinophils and modulates activation state and chemotaxis. J. Allergy Clin. Immunol., 104, 136144.